In models of obesity, acetate supplementation has been observed to decrease blood triglyceride and total cholesterol concentrations while increasing glucagon-like peptide-1 (GLP-1) and leptin concentrations [37]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.